-
-
-
-
-
-
-
CNS Pharmaceuticals names Rami Levin as new president and CEO
-
-
-
-
-
-
-
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
-
-
-
-
-
-
-
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
-
-
-
-
-
-
-
CNS Pharmaceuticals (CNSP) Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
-
-
-
-
-
-
-
CNS Pharmaceuticals (CNSP) announces 1-for-50 reverse stock split
-
-
-
-
-
-
-
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
-
-
-
-
-
-
-
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

